CD1C and rheumatoid arthritis: To extend the studies to the clinical setting, we first over-expressed miR-34a in blood monocyte-derived inflammatory DCs from healthy donors to mimic the constitutively raised miR-34a expression in RA CD1c+ DCs (Fig. 1), and stimulated them with LPS or CL097.